Lyell Immunopharma
Advanced T-cell Cancer Therapies
- B2C
About Lyell Immunopharma
Develops advanced CAR T-cell therapies for cancer patients, focusing on T-cells that resist exhaustion and have durable stemness for long-lasting clinical response.
Key facts
- Industry
- Biotechnology Research
- Company size
- 51–250 employees
- Headquarters
- South San Francisco, California, United States
- Founded
- 2018
- Revenue
- $36KFY2025, publicly reported
- Website
- lyell.com
- linkedin.com/company/lyell
Lyell Immunopharma at a glance
Lyell Immunopharma is a B2C company in the Biotechnology Research industry, headquartered in South San Francisco, California, United States.
Lyell Immunopharma was founded in 2018.
Lyell Immunopharma has 51–250 employees.
Lyell Immunopharma's revenue is $36K (FY2025, publicly reported).
Selling to companies like Lyell Immunopharma?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies